Rxivist logo

HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2

By Ji Cao, Lei Sun, Pornpun Aramsangtienchai, Nicole A. Spiegelman, Xiaoyu Zhang, Edward Seto, Hening Lin

Posted 31 Oct 2017
bioRxiv DOI: 10.1101/211706 (published DOI: 10.1073/pnas.1815365116)

The smallest histone deacetylase (HDAC) and the only class IV HDAC member, HDAC11, is reported to regulate immune activation and tumorigenesis, yet its physiological function is largely unknown. Here we identify HDAC11 as an efficient lysine defatty-acylase that is >10,000-fold more efficient than its deacetylase activity. Through proteomics studies, we identified SHMT2 as a defatty-acylation substrate of HDAC11. HDAC11-catalyzed defatty-acylation did not affect the enzymatic activity of SHMT2. Instead, it affects the ability of SHMT2 to regulate type I interferon receptor ubiquitination and internalization. Correspondingly, HDAC11 depletion increased type I interferon signaling in both cell culture and mice. This study is the first time a zinc-dependent HDAC is found to have an activity that is much more efficient than the corresponding deacetylase activity. The finding expands the physiological functions of HDAC11 and protein lysine fatty acylation, and opens up opportunities to develop HDAC11-specific inhibitors as therapeutics to modulate immune responses.

Download data

  • Downloaded 767 times
  • Download rankings, all-time:
    • Site-wide: 28,700
    • In biochemistry: 674
  • Year to date:
    • Site-wide: 71,339
  • Since beginning of last month:
    • Site-wide: 63,809

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)